TaiMed Biologics Inc. (4147.TWO)
TWD 82.5
(-0.48%)
TWD 82.5
(-0.48%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 225.23 Million TWD | 4.41% |
| 2022 | 215.71 Million TWD | 156.94% |
| 2021 | 83.95 Million TWD | -73.87% |
| 2020 | 321.24 Million TWD | 39.66% |
| 2019 | 230.01 Million TWD | 1258.34% |
| 2018 | -19.85 Million TWD | -335.38% |
| 2017 | 8.43 Million TWD | 697.87% |
| 2016 | -1.41 Million TWD | 58.89% |
| 2015 | -3.43 Million TWD | 0.0% |
| 2014 | - TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | -100.0% |
| 2011 | 135 Thousand TWD | 0.0% |
| 2010 | - TWD | 0.0% |
| 2009 | - TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 53.45 Million TWD | -22.66% |
| 2024 Q2 | 46.06 Million TWD | 8.39% |
| 2023 Q2 | 33.88 Million TWD | -24.55% |
| 2023 FY | 225.23 Million TWD | 4.41% |
| 2023 Q1 | 44.9 Million TWD | -65.65% |
| 2023 Q4 | 69.1 Million TWD | -10.63% |
| 2023 Q3 | 77.33 Million TWD | 128.24% |
| 2022 Q2 | 50.47 Million TWD | 8326.54% |
| 2022 Q1 | 599 Thousand TWD | 101.18% |
| 2022 FY | 215.71 Million TWD | 156.94% |
| 2022 Q4 | 130.72 Million TWD | 285.5% |
| 2022 Q3 | 33.91 Million TWD | -32.82% |
| 2021 Q4 | -50.89 Million TWD | -219.31% |
| 2021 FY | 83.95 Million TWD | -73.87% |
| 2021 Q1 | 30.2 Million TWD | -51.96% |
| 2021 Q2 | 61.98 Million TWD | 105.19% |
| 2021 Q3 | 42.65 Million TWD | -31.18% |
| 2020 Q1 | 128.82 Million TWD | 59.14% |
| 2020 FY | 321.24 Million TWD | 39.66% |
| 2020 Q2 | 74.43 Million TWD | -42.22% |
| 2020 Q3 | 55.09 Million TWD | -25.98% |
| 2020 Q4 | 62.88 Million TWD | 14.13% |
| 2019 Q4 | 80.95 Million TWD | -19.55% |
| 2019 Q1 | 21.54 Million TWD | -3.86% |
| 2019 Q2 | 26.88 Million TWD | 24.79% |
| 2019 FY | 230.01 Million TWD | 1258.34% |
| 2019 Q3 | 100.62 Million TWD | 274.24% |
| 2018 Q2 | -7.31 Million TWD | -5.49% |
| 2018 Q4 | 22.41 Million TWD | 179.98% |
| 2018 Q3 | -28.01 Million TWD | -283.02% |
| 2018 Q1 | -6.93 Million TWD | -388.2% |
| 2018 FY | -19.85 Million TWD | -335.38% |
| 2017 Q2 | 2.4 Million TWD | 97.78% |
| 2017 FY | 8.43 Million TWD | 697.87% |
| 2017 Q4 | 2.4 Million TWD | 0.0% |
| 2017 Q1 | 1.21 Million TWD | 95.35% |
| 2017 Q3 | 2.4 Million TWD | -0.04% |
| 2016 FY | -1.41 Million TWD | 58.89% |
| 2016 Q4 | 623 Thousand TWD | 0.0% |
| 2016 Q3 | 623 Thousand TWD | 0.16% |
| 2016 Q2 | 622 Thousand TWD | 199.04% |
| 2016 Q1 | 208 Thousand TWD | 0.0% |
| 2015 Q1 | - TWD | 0.0% |
| 2015 FY | -3.43 Million TWD | 0.0% |
| 2015 Q4 | - TWD | 0.0% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2014 Q2 | - TWD | 0.0% |
| 2014 FY | - TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | - TWD | 0.0% |
| 2014 Q4 | - TWD | 0.0% |
| 2013 Q1 | - TWD | 0.0% |
| 2013 Q2 | - TWD | 0.0% |
| 2013 Q3 | - TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2013 Q4 | - TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | - TWD | -100.0% |
| 2012 Q3 | - TWD | 0.0% |
| 2012 Q4 | - TWD | 0.0% |
| 2011 FY | 135 Thousand TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 Q2 | - TWD | 0.0% |
| 2010 FY | - TWD | 0.0% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -20697.138% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -87.835% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 1976.629% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | -194.966% |
| NaviFUS Corp. | 11.82 Million TWD | -1804.397% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | -55.777% |
| TaiRx, Inc. | 2.43 Million TWD | -9134.645% |
| Sinew Pharma Inc. | -28.98 Million TWD | 877.067% |
| Lin BioScience, Inc. | -17.92 Million TWD | 1356.39% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -890.383% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -442.979% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -68359.878% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 44.048% |
| AP Biosciences Inc | 32.25 Million TWD | -598.332% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 83.968% |
| RBC Bioscience Corporation | 72.89 Million TWD | -208.983% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 65.021% |
| EirGenix Inc. | 236.74 Million TWD | 4.861% |
| Enimmune corporation | -23.37 Million TWD | 1063.646% |
| Lukas Biomedical Inc. | 133.89 Million TWD | -68.222% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -250158.889% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -4170.63% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 160.032% |
| TCI GENE Inc. | 174.61 Million TWD | -28.987% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -43130.902% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | -591.705% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 5690.295% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | -179.027% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 2579.174% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 2412.691% |
| Neith Corporation | 18.01 Million TWD | -1149.975% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 21.116% |
| VBI | 16.42 Million TWD | -1271.449% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 53.537% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -716.535% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -3278.326% |
| CHO Pharma, Inc. | -28.27 Million TWD | 896.467% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -71859.425% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 1456.744% |
| Visgeneer Inc. | 67.48 Million TWD | -233.768% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 42.61% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -115.842% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | -132.741% |
| Sagittarius Life Science Corp | 71.47 Million TWD | -215.113% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | -151.326% |
| GlycoNex Incorporation | 995 Thousand TWD | -22536.482% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 63.515% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 28.384% |
| PharmaEngine, Inc. | 718.97 Million TWD | 68.673% |
| Intech Biopharm Corporation | -163.99 Million TWD | 237.341% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | -13.493% |
| BiOptic Inc. | 152.74 Million TWD | -47.457% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | -101.666% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 2314.027% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | -192.651% |
| OBI Pharma, Inc. | -73.49 Million TWD | 406.452% |
| Savior Lifetec Corporation | 220.94 Million TWD | -1.939% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -8513.117% |
| Level Biotechnology Inc. | 219.54 Million TWD | -2.591% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 2.167% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -62.19% |
| Acepodia, Inc. | 16.59 Million TWD | -1257.398% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -719.953% |